Cargando…
A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort
Background. Patients with ulcerative colitis have an increased risk of developing colorectal cancer (CRC). The aim of this study is to assess the yield of surveillance colonoscopies in a tertiary referral cohort of ulcerative colitis patients and to identify different risk groups for dysplasia. Meth...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863532/ https://www.ncbi.nlm.nih.gov/pubmed/24379739 http://dx.doi.org/10.1155/2013/274715 |
_version_ | 1782295831960879104 |
---|---|
author | Stolwijk, J. A. M. Langers, A. M. J. Hardwick, J. C. Veenendaal, R. A. Verspaget, H. W. van Hogezand, R. A. Vasen, H. F. van der Meulen-de Jong, A. E. |
author_facet | Stolwijk, J. A. M. Langers, A. M. J. Hardwick, J. C. Veenendaal, R. A. Verspaget, H. W. van Hogezand, R. A. Vasen, H. F. van der Meulen-de Jong, A. E. |
author_sort | Stolwijk, J. A. M. |
collection | PubMed |
description | Background. Patients with ulcerative colitis have an increased risk of developing colorectal cancer (CRC). The aim of this study is to assess the yield of surveillance colonoscopies in a tertiary referral cohort of ulcerative colitis patients and to identify different risk groups for dysplasia. Methods. A cohort of 293 patients (148 males, mean age 33.8 years at diagnosis) was built up at our center and started the surveillance program 8–12 years after start of symptoms. They underwent colonoscopies every one to three years. Endpoints were dysplasia or a (sub)total colectomy. Results. After a follow-up period of 10 years, the cumulative incidence of any dysplasia was 23.5%, and of CRC 4.0%. After 15 years these percentages were 33.3% and 6.8%. Patients with pancolitis (n = 178) had a significantly higher cumulative risk of dysplasia than patients with distal disease, HR 1.9 (95%CI 1.1–3.3). Patients who started surveillance at an older age are at increased risk for any dysplasia, HR 1.03 (95%CI 1.01–1.05). Conclusions. This prospective surveillance study shows a high yield of dysplasia in ulcerative colitis patients. We recommend developing separate surveillance programs for different risk groups. In our opinion patients with distal colitis can follow the general population surveillance program. |
format | Online Article Text |
id | pubmed-3863532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38635322013-12-30 A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort Stolwijk, J. A. M. Langers, A. M. J. Hardwick, J. C. Veenendaal, R. A. Verspaget, H. W. van Hogezand, R. A. Vasen, H. F. van der Meulen-de Jong, A. E. ScientificWorldJournal Clinical Study Background. Patients with ulcerative colitis have an increased risk of developing colorectal cancer (CRC). The aim of this study is to assess the yield of surveillance colonoscopies in a tertiary referral cohort of ulcerative colitis patients and to identify different risk groups for dysplasia. Methods. A cohort of 293 patients (148 males, mean age 33.8 years at diagnosis) was built up at our center and started the surveillance program 8–12 years after start of symptoms. They underwent colonoscopies every one to three years. Endpoints were dysplasia or a (sub)total colectomy. Results. After a follow-up period of 10 years, the cumulative incidence of any dysplasia was 23.5%, and of CRC 4.0%. After 15 years these percentages were 33.3% and 6.8%. Patients with pancolitis (n = 178) had a significantly higher cumulative risk of dysplasia than patients with distal disease, HR 1.9 (95%CI 1.1–3.3). Patients who started surveillance at an older age are at increased risk for any dysplasia, HR 1.03 (95%CI 1.01–1.05). Conclusions. This prospective surveillance study shows a high yield of dysplasia in ulcerative colitis patients. We recommend developing separate surveillance programs for different risk groups. In our opinion patients with distal colitis can follow the general population surveillance program. Hindawi Publishing Corporation 2013-11-28 /pmc/articles/PMC3863532/ /pubmed/24379739 http://dx.doi.org/10.1155/2013/274715 Text en Copyright © 2013 J. A. M. Stolwijk et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Stolwijk, J. A. M. Langers, A. M. J. Hardwick, J. C. Veenendaal, R. A. Verspaget, H. W. van Hogezand, R. A. Vasen, H. F. van der Meulen-de Jong, A. E. A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort |
title | A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort |
title_full | A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort |
title_fullStr | A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort |
title_full_unstemmed | A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort |
title_short | A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort |
title_sort | thirty-year follow-up surveillance study for neoplasia of a dutch ulcerative colitis cohort |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863532/ https://www.ncbi.nlm.nih.gov/pubmed/24379739 http://dx.doi.org/10.1155/2013/274715 |
work_keys_str_mv | AT stolwijkjam athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT langersamj athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT hardwickjc athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT veenendaalra athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT verspagethw athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT vanhogezandra athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT vasenhf athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT vandermeulendejongae athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT stolwijkjam thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT langersamj thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT hardwickjc thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT veenendaalra thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT verspagethw thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT vanhogezandra thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT vasenhf thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort AT vandermeulendejongae thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort |